The View from A Farr – Action on obesity
By Annette Farr | 31 January 2008
Rising obesity statistics make alarming reading for governments and for the drinks industry. While politicians look to improve the effectiveness of their policies in this area, writes Annette Farr, with all eyes on the raft of initiatives unveiled in the UK last week, the drinks industry is demonstrating its commitment to tackling the problems through product innovation.
just-drinks articles are only available to registered users and members.
Join now for increased access
There are various access options to choose from. All provide instant access to the latest news, insight and expert analysis.
If you’re already a member, login here.
Rising obesity statistics make alarming reading for governments and for the drinks industry. While politicians look to improve the effectiveness of their policies in this area, writes Annette Farr, with all eyes on the raft of initiatives unveiled in the UK last week, the drinks industry is demonstrating its commitment to tackling the problems through product innovation.
- Unlimited access to all the latest global beverage news and insight
- Expert analysis that puts the news into context
- Exclusive interviews with leading industry figures
- Monthly management briefings with detailed analysis on hot topics
- Personalised RSS feeds and email newsletters
- 10-year archive of news, insight and intelligence
- Discounts on just-drinks market research
- Plus much more
If you’re already a member, login here
More articles related to this one
US: Dr Pepper Snapple Group bunks up with Hydrive
Dr Pepper Snapple Group has acquired a minority stake in Hydrive Energy in the US.
US: DC Brands appoints sales director
Energy drink manufacturer DC Brands International has appointed Ashley Coors as national director of distributor sales.
US: Redux accelerates Cocaine rebranding on FDA pressure
Redux Beverages is to repackage its Cocaine brand. The move comes only months after the product was withdrawn and relaunched following pressure from the Food and Drug Administration (FDA).
